161 related articles for article (PubMed ID: 30625177)
1. Interpretation of CVD risk predictions in clinical practice: Mission impossible?
Lagerweij GR; Moons KGM; de Wit GA; Koffijberg H
PLoS One; 2019; 14(1):e0209314. PubMed ID: 30625177
[TBL] [Abstract][Full Text] [Related]
2. Predicted burden could replace predicted risk in preventive strategies for cardiovascular disease.
Lagerweij GR; de Wit GA; Moons KGM; Verschuren WMM; Boer JMA; Koffijberg H
J Clin Epidemiol; 2018 Jan; 93():103-111. PubMed ID: 28943378
[TBL] [Abstract][Full Text] [Related]
3. Comparing six cardiovascular risk prediction models in Haiti: implications for identifying high-risk individuals for primary prevention.
Yan LD; Lookens Pierre J; Rouzier V; Théard M; Apollon A; St Preux S; Kingery JR; Jamerson KA; Deschamps M; Pape JW; Safford MM; McNairy ML
BMC Public Health; 2022 Mar; 22(1):549. PubMed ID: 35305599
[TBL] [Abstract][Full Text] [Related]
4. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
Albarqouni L; Doust JA; Magliano D; Barr EL; Shaw JE; Glasziou PP
Med J Aust; 2019 Mar; 210(4):161-167. PubMed ID: 30656697
[TBL] [Abstract][Full Text] [Related]
5. A new selection method to increase the health benefits of CVD prevention strategies.
Lagerweij GR; de Wit GA; Moons KG; van der Schouw YT; Verschuren WM; Dorresteijn JA; Koffijberg H;
Eur J Prev Cardiol; 2018 Apr; 25(6):642-650. PubMed ID: 29411690
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cardiovascular risk assessment tools and their guidelines in evaluation of 10-year CVD risk and preventive recommendations: A population based study.
Motamed N; Rabiee B; Perumal D; Poustchi H; Miresmail SJ; Farahani B; Maadi M; Saeedian FS; Ajdarkosh H; Khonsari MR; Hemasi GR; Zamani F
Int J Cardiol; 2017 Feb; 228():52-57. PubMed ID: 27863362
[TBL] [Abstract][Full Text] [Related]
7. Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis.
Damen JA; Pajouheshnia R; Heus P; Moons KGM; Reitsma JB; Scholten RJPM; Hooft L; Debray TPA
BMC Med; 2019 Jun; 17(1):109. PubMed ID: 31189462
[TBL] [Abstract][Full Text] [Related]
8. Temporal trends in cardiovascular risk factors and performance of the Framingham Risk Score and the Pooled Cohort Equations.
Rospleszcz S; Thorand B; de Las Heras Gala T; Meisinger C; Holle R; Koenig W; Mansmann U; Peters A
J Epidemiol Community Health; 2019 Jan; 73(1):19-25. PubMed ID: 30262553
[TBL] [Abstract][Full Text] [Related]
9. The relevance of competing risk adjustment in cardiovascular risk prediction models for clinical practice.
Hageman SHJ; Dorresteijn JAN; Pennells L; van Smeden M; Bots ML; Di Angelantonio E; Visseren FLJ
Eur J Prev Cardiol; 2023 Nov; 30(16):1741-1747. PubMed ID: 37338108
[TBL] [Abstract][Full Text] [Related]
10. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
[TBL] [Abstract][Full Text] [Related]
11. Prediction of cardiovascular risk using Framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk?
van Staa TP; Gulliford M; Ng ES; Goldacre B; Smeeth L
PLoS One; 2014; 9(10):e106455. PubMed ID: 25271417
[TBL] [Abstract][Full Text] [Related]
12. Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies.
Pennells L; Kaptoge S; Wood A; Sweeting M; Zhao X; White I; Burgess S; Willeit P; Bolton T; Moons KGM; van der Schouw YT; Selmer R; Khaw KT; Gudnason V; Assmann G; Amouyel P; Salomaa V; Kivimaki M; Nordestgaard BG; Blaha MJ; Kuller LH; Brenner H; Gillum RF; Meisinger C; Ford I; Knuiman MW; Rosengren A; Lawlor DA; Völzke H; Cooper C; Marín Ibañez A; Casiglia E; Kauhanen J; Cooper JA; Rodriguez B; Sundström J; Barrett-Connor E; Dankner R; Nietert PJ; Davidson KW; Wallace RB; Blazer DG; Björkelund C; Donfrancesco C; Krumholz HM; Nissinen A; Davis BR; Coady S; Whincup PH; Jørgensen T; Ducimetiere P; Trevisan M; Engström G; Crespo CJ; Meade TW; Visser M; Kromhout D; Kiechl S; Daimon M; Price JF; Gómez de la Cámara A; Wouter Jukema J; Lamarche B; Onat A; Simons LA; Kavousi M; Ben-Shlomo Y; Gallacher J; Dekker JM; Arima H; Shara N; Tipping RW; Roussel R; Brunner EJ; Koenig W; Sakurai M; Pavlovic J; Gansevoort RT; Nagel D; Goldbourt U; Barr ELM; Palmieri L; Njølstad I; Sato S; Monique Verschuren WM; Varghese CV; Graham I; Onuma O; Greenland P; Woodward M; Ezzati M; Psaty BM; Sattar N; Jackson R; Ridker PM; Cook NR; D'Agostino RB; Thompson SG; Danesh J; Di Angelantonio E;
Eur Heart J; 2019 Feb; 40(7):621-631. PubMed ID: 30476079
[TBL] [Abstract][Full Text] [Related]
13. Validation of the general Framingham Risk Score (FRS), SCORE2, revised PCE and WHO CVD risk scores in an Asian population.
Kasim SS; Ibrahim N; Malek S; Ibrahim KS; Aziz MF; Song C; Chia YC; Ramli AS; Negishi K; Mat Nasir N
Lancet Reg Health West Pac; 2023 Jun; 35():100742. PubMed ID: 37424687
[TBL] [Abstract][Full Text] [Related]
14. Traditional Cardiovascular Risk Factors Strongly Underestimate the 5-Year Occurrence of Cardiovascular Morbidity and Mortality in Spinal Cord Injured Individuals.
Barton TJ; Low DA; Bakker EA; Janssen T; de Groot S; van der Woude L; Thijssen DHJ
Arch Phys Med Rehabil; 2021 Jan; 102(1):27-34. PubMed ID: 32861666
[TBL] [Abstract][Full Text] [Related]
15. An observational study of how clinicians use cardiovascular risk assessment to inform statin prescribing decisions.
Robinson T; Jackson R; Wells S; Kerr A; Marshall R
N Z Med J; 2017 Oct; 130(1463):28-38. PubMed ID: 28981492
[TBL] [Abstract][Full Text] [Related]
16. Validation of the Framingham General Cardiovascular Risk Score and Pooled Cohort Equations in a Community-Based Population: A Prospective Cohort Study Analysis 2006-2017.
Jian JZ; Tzeng IS; Hsieh CF; Huang HL; Chen CL; Liu KL
Acta Cardiol Sin; 2023 Nov; 39(6):879-887. PubMed ID: 38022424
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease risk prediction in sub-Saharan African populations - Comparative analysis of risk algorithms in the RODAM study.
Boateng D; Agyemang C; Beune E; Meeks K; Smeeth L; Schulze MB; Addo J; de-Graft Aikins A; Galbete C; Bahendeka S; Danquah I; Agyei-Baffour P; Owusu-Dabo E; Mockenhaupt FP; Spranger J; Kengne AP; Grobbee DE; Klipstein-Grobusch K
Int J Cardiol; 2018 Mar; 254():310-315. PubMed ID: 29407113
[TBL] [Abstract][Full Text] [Related]
18. Does the addition of serum antimüllerian hormone concentrations to the Framingham Risk Score and Pooled Cohort Equations improve the prediction of cardiovascular disease?
Amiri M; Ahmadi N; Hadaegh F; Mousavi M; Azizi F; Ramezani Tehrani F
Menopause; 2023 Apr; 30(4):406-413. PubMed ID: 36720078
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
